GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Luxbright AB (OSTO:LXB) » Definitions » Net Cash per Share

Luxbright AB (OSTO:LXB) Net Cash per Share : kr0.26 (As of Jun. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Luxbright AB Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Luxbright AB's Net Cash per Share for the quarter that ended in Jun. 2023 was kr0.26.

The historical rank and industry rank for Luxbright AB's Net Cash per Share or its related term are showing as below:

OSTO:LXB' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 2.73   Med: 4.45   Max: 16.47
Current: 3.96

During the past 5 years, the highest Price-to-Net-Cash Ratio of Luxbright AB was 16.47. The lowest was 2.73. And the median was 4.45.

OSTO:LXB's Price-to-Net-Cash is ranked better than
65.97% of 335 companies
in the Medical Devices & Instruments industry
Industry Median: 7.02 vs OSTO:LXB: 3.96

Luxbright AB Net Cash per Share Historical Data

The historical data trend for Luxbright AB's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Luxbright AB Net Cash per Share Chart

Luxbright AB Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
Net Cash per Share
- 0.05 0.79 0.14 0.09

Luxbright AB Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Net Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.53 0.14 0.42 0.09 0.26

Competitive Comparison of Luxbright AB's Net Cash per Share

For the Medical Devices subindustry, Luxbright AB's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Luxbright AB's Price-to-Net-Cash Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Luxbright AB's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Luxbright AB's Price-to-Net-Cash falls into.



Luxbright AB Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Luxbright AB's Net Cash per Share for the fiscal year that ended in Dec. 2022 is calculated as

Net Cash per Share (A: Dec. 2022 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(7.598-3.328-0)/45.1052
=0.09

Luxbright AB's Net Cash per Share for the quarter that ended in Jun. 2023 is calculated as

Net Cash per Share (Q: Jun. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(25.417-1.86-0)/91.4965
=0.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Luxbright AB  (OSTO:LXB) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


Luxbright AB Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Luxbright AB's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Luxbright AB (OSTO:LXB) Business Description

Traded in Other Exchanges
Address
Arvid Wallgrens backe 20, Gothenburg, SWE, 41346
Luxbright AB is a technology company focusing on developing and commercializing a new generation of X-ray tubes. The company offers innovative X-ray tubes, generators, and future X-ray systems to international system suppliers in order to improve and protect lives by enabling higher resolution X-ray images. The X-ray tubes are a powerful, stable, and cost-effective alternative to conventional X-ray tubes.

Luxbright AB (OSTO:LXB) Headlines

No Headlines